Rx/Reimbursement Adult Incontinence in Australia

While demand for rx/reimbursement adult incontinence in Australia continued to steadily rise in 2024, value growth was much higher. By increasing awareness and education among healthcare professionals, particularly in general practice settings, more individuals experiencing incontinence are being identified and referred, which is resulting in an increase in the utilisation of prescription or reimbursed adult incontinence products as part of a management approach.

The Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Rx/Reimbursement adult incontinence market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.